Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections-Reference-Cited by-同舟云学术

Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections

Published:2018-08 Issue:12 Volume:78 Page:1259-1270
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Dhillon Sohita

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/article/10.1007/s40265-018-0966-7/fulltext.html

Reference56 articles.

1. Vallejo-Torres L, Pujol M, Shaw E, et al. Cost of hospitalised patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the COMBACTE-MAGNET, RESCUING study. BMJ Open. 2018;8(4):e020251.

2. Flores-Mireles AL, Walker JN, Caparon M, et al. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269–84.

3. European Association of Urology. Guidelines on urological infections. 2015. https://uroweb.org/wp-content/uploads/19-Urological-infections_LR2.pdf . Accessed 30 July 2018.

4. US Center for Drug Evaluation and Research. Clinical review(s). 2016. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209776Orig1s000MedR.pdf . Accessed 30 July 2018.

5. Ma AH, Hughes GJ. Updates in management of complicated urinary tract infections: a focus on multidrug-resistant organisms. Am J Ther. 2018;25:e53–66.

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic Review and Meta-Analysis of Clinical Efficacy and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections;International Journal of Molecular Sciences;2024-09-04

2. Peptide-mimetic treatment of Pseudomonas aeruginosa in a mouse model of respiratory infection;Communications Biology;2024-08-22

3. Recent Advances in the Development of Metal/Metal Oxide Nanoparticle and Antibiotic Conjugates (MNP–Antibiotics) to Address Antibiotic Resistance: Review and Perspective;International Journal of Molecular Sciences;2024-08-16

4. Dose rationale for the use of meropenem/vaborbactam combination in paediatric patients with Gram‐negative bacterial infections;British Journal of Clinical Pharmacology;2024-06-26

5. Hexafluoroisopropanol Promoted Ring‐Opening‐Cyclization of Donor–Acceptor Cyclopropanes with Primary Amines;European Journal of Organic Chemistry;2024-04-10